UN trial for virus therapies pauses testing on Trump's drug

The World Health Organization said Monday that it will temporarily drop hydroxychloroquine -- the malaria drug U.S. President Trump says he is taking -- from its global study into experimental COVID-19 treatments, saying that its experts need to review all available evidence to date.